IL2 and central nervous system cancer: Further cell experiments revealed that RUNX1 could regulate the transcription and expression of IFNGR2 as well as participate in glioma cell proliferation, cycle, apoptosis, invasion, and migration, which may be realized through the IL2-STAT5 pathway.